Scientists
Researchers from Wakayama, Japan have investigated the effect of cyclin-dependent kinase 1 (CDK1) inhibition on p53 signaling in acute myeloid leukemia (AML) cells. The study, published in Cancer Science, found that treatment with the CDK1 inhibitor RO-3306 induces G2/M-phase cell cycle arrest and apoptosis in AML cells in a
Universities and colleges
Researchers in Suita, Japan have identified a molecular target associated with the progression of gastric cancer, a tumor suppressor gene called FBXW7. This gene is transcriptionally controlled by p53 and plays a crucial role in cell cycle regulation. The study found that low expression levels of FBXW7 in primary gastric
Scientists
Scientists in the United States have reported that the DNA cross-linking agents cisplatin and oxaliplatin, widely used in cancer treatment, activate the G(1) and G(2) cell cycle checkpoints. However, the role of the intra-S-phase checkpoint in the response to these agents is less understood. Researchers at the Mayo
Universities and colleges
Researchers from Cardiff University have made significant strides in the fight against breast cancer, discovering a novel approach to treating tumors caused by mutations in the BRCA2 gene. The study, published in Cancer Research, found that inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) effectively regresses tumors in mice with deficiencies in
Scientists
A study by D. Sampath and colleagues at the University of Texas has identified a novel regulatory mechanism in chronic lymphocytic leukemia (CLL) cells. The researchers found that deacetylase inhibition leads to the activation of the microRNA miR106b, which targets the ubiquitin ligase Itch for degradation. This event results in
Universities and colleges
Scientists in Turin, Italy, investigated the expression of genes involved in DNA repair and replication as predictive markers of response to chemotherapy in non-small cell lung cancer (NSCLC). The study evaluated differential mRNA levels of 22 DNA repair genes and 6 genes involved in DNA replication in tumors compared to
Scientists
A recent study from Washington University, Medical Department, has made significant advancements in the treatment of pancreatic cancer. Researchers discovered that sigma-2 receptor ligands, specifically SV119, can potentiate conventional chemotherapies, such as gemcitabine and paclitaxel, to induce apoptosis in pancreatic cancer cells. This combination therapy demonstrated a survival benefit in
Universities and colleges
Researchers at Washington University have found that an underappreciated relationship between temporal apoptotic response and caspase-activation determines the response of breast and lung tumor cell lines to chemotherapy. The study, published in Cancer Investigation, highlights the significance of targeting caspase cleavage to increase the potency of cancer drugs. The researchers
Universities and colleges
Scientists have made new findings in immunotherapy, particularly in the treatment of melanoma, through the discovery of a novel phosphorylated STAT3 inhibitor. According to a study, this inhibitor, WP1066, enhances T cell cytotoxicity against melanoma by inhibiting regulatory T cells (Tregs). The activation of STAT3 has been identified as a
Scientists
Recent research published in the journal Cell Cycle has identified the anti-diabetic drug metformin as a potential therapeutic agent against breast cancer cells. The study found that metformin inhibited the growth and colony formation of breast cancer cell lines, including those that were estrogen receptor-positive and negative, and erbB2-overexpressing and
Universities and colleges
Researchers in Innsbruck, Austria have made significant progress in understanding the potential of Langerhans cells, a subset of skin dendritic cells, for immunotherapy. These cells play a crucial role in surveying peripheral tissue for invading pathogens and can present exogenous antigen to CD4+ and CD8+ T cells. A recent study
Scientists
Researchers at the University of Tubingen, Germany have made a surprising discovery that interferon-gamma (IFN-gamma)-producing CD4(+) T helper cells (Th1) can be highly effective in tumor prevention and therapy, but early trials in humans have shown that tumor immune therapy may actually promote tumor progression. The study found that
